Allergy Therapeutics PLC
LSE:AGY

Watchlist Manager
Allergy Therapeutics PLC Logo
Allergy Therapeutics PLC
LSE:AGY
Watchlist
Price: 5.42 GBX -3.21% Market Closed
Market Cap: 258.3m GBX
Have any thoughts about
Allergy Therapeutics PLC?
Write Note

Allergy Therapeutics PLC
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Allergy Therapeutics PLC
Cost of Revenue Peer Comparison

Comparables:
GSK
AZN
VRNA
HIK
DPH

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Allergy Therapeutics PLC
LSE:AGY
Cost of Revenue
-ÂŁ25.3m
CAGR 3-Years
-7%
CAGR 5-Years
-7%
CAGR 10-Years
-8%
GlaxoSmithKline PLC
LSE:GSK
Cost of Revenue
-ÂŁ8.5B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
-1%
AstraZeneca PLC
LSE:AZN
Cost of Revenue
-$8.7B
CAGR 3-Years
-8%
CAGR 5-Years
-14%
CAGR 10-Years
-5%
Verona Pharma PLC
NASDAQ:VRNA
Cost of Revenue
-$543k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hikma Pharmaceuticals PLC
LSE:HIK
Cost of Revenue
-$1.6B
CAGR 3-Years
-10%
CAGR 5-Years
-9%
CAGR 10-Years
-10%
Dechra Pharmaceuticals PLC
LSE:DPH
Cost of Revenue
-ÂŁ331.9m
CAGR 3-Years
-14%
CAGR 5-Years
-13%
CAGR 10-Years
-14%

See Also

What is Allergy Therapeutics PLC's Cost of Revenue?
Cost of Revenue
-25.3m GBP

Based on the financial report for Dec 31, 2023, Allergy Therapeutics PLC's Cost of Revenue amounts to -25.3m GBP.

What is Allergy Therapeutics PLC's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-8%

Over the last year, the Cost of Revenue growth was -3%. The average annual Cost of Revenue growth rates for Allergy Therapeutics PLC have been -7% over the past three years , -7% over the past five years , and -8% over the past ten years .

Back to Top